Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology
Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune status SAN ...
eLife6d
The antigenic landscape of N1 neuraminidase in human influenza A virus strains isolated between 2009 and 2020
Catani and colleagues provide data on antigenic properties of neuraminidase proteins of pandemic H1N1 and show that antigenic diversity of the neuraminidase from 2009 to 2020 largely falls into two ...
Hosted on MSN1mon
A new strain of bird flu is found on a California duck farm
Flu viruses are composed of eight segments, including the haemagglutinin protein, or "H" part of the virus, and neuraminidase, or the "N" part. When an animal is infected by two different flu ...
Medscape9y
Complementary Assays Helping to Overcome Challenges for Identifying Neuraminidase Inhibitors
Aims In this study, we analyze the challenges involved in detecting novel neuraminidase inhibitors (NAIs) and offer strategies to overcome them with complementary bioassays. Materials & Methods We ...
Hosted on MSN1mon
Cantor Fitzgerald raises Cidara stock to Overweight
Schmidt remarked on the drug's ability to target neuraminidase, a key receptor for the influenza virus, suggesting that CD388 could become a significant preventative treatment for a wide array of ...
Cidara Therapeutics: CD388 preclinical data published in Nature Microbiology
Cidara Therapeutics (CDTX) announced the publication of preclinical data assessing CD388, the company’s influenza DFC, in the peer-reviewed ...